
The most lethal reproductive cancer in women, ovarian cancer, is estimated to affect 12.8 per 100,000 women in the United States. As such, researchers continue to look into novel ways to eradicate the disease. Armed with the knowledge that almost all (90%) ovarian cancers can be characterized by their expression of alpha-folate receptor, Dr De-Gang Song, postdoctoral investigator in the Perelman School of Medicine at the University of Pennsylvania, and colleagues attempted to engineer T cells to see if they would help shrink the cancer tumors.



